Cargando…
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new acronym adopted from the consensus of international experts. Given the increasing prevalence of MAFLD in pre-transplant settings, de novo and recurrent graft steatosis/MAFLD are common in post-transplant settings. The impact of gr...
Autores principales: | Han, Ma Ai Thanda, Olivo, Raquel, Choi, Catherine J, Pyrsopoulos, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727208/ https://www.ncbi.nlm.nih.gov/pubmed/35070003 http://dx.doi.org/10.4254/wjh.v13.i12.1991 |
Ejemplares similares
-
Expanding indications for liver transplantation in the era of liver transplant oncology
por: Panayotova, Guergana, et al.
Publicado: (2021) -
Liver transplant allocation policies and outcomes in United States: A comprehensive review
por: Latt, Nyan L, et al.
Publicado: (2022) -
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
por: Han, Ma Ai Thanda, et al.
Publicado: (2021) -
Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis
por: Harputluoglu, Murat, et al.
Publicado: (2022) -
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)